×

Login

  • Lost Password

SIGN IN YOUR ACCOUNT TO HAVE ACCESS TO DIFFERENT FEATURES

CREATE AN ACCOUNT FORGOT YOUR PASSWORD?

FORGOT YOUR DETAILS?

AAH, WAIT, I REMEMBER NOW!

CREATE ACCOUNT

ALREADY HAVE AN ACCOUNT?

Karma1

  • The most followed
  • New technologies
  • What is Karma1
    • How does it work?
    • What are the karmas?
  • Tell us your opinion
  • SIGN UP
  • LOGIN
Advanced Search
  • Aerospace
    • K 5
    • K 4
    • K 3
    • K 2
    • K 1
    • ALL
  • Energy
    • K 5
    • K 4
    • K 3
    • K 2
    • K 1
    • ALL
  • Environment
    • K 5
    • K 4
    • K 3
    • K 2
    • K 1
    • ALL
  • Hardware
    • K 5
    • K 4
    • K 3
    • K 2
    • K 1
    • ALL
  • Health & life sciences
    • K 5
    • K 4
    • K 3
    • K 2
    • K 1
    • ALL
  • Manufacturing technologies
    • K 5
    • K 4
    • K 3
    • K 2
    • K 1
    • ALL
  • Materials
    • K 5
    • K 4
    • K 3
    • K 2
    • K 1
    • ALL
  • Robotics
    • K 5
    • K 4
    • K 3
    • K 2
    • K 1
    • ALL
  • Software
    • K 5
    • K 4
    • K 3
    • K 2
    • K 1
    • ALL
  • Transport
    • K 5
    • K 4
    • K 3
    • K 2
    • K 1
    • ALL

Body Vision Medical Receives FDA Clearance for LungVision 2.0 System, a Part of LungVision Platform, Demonstrated at ATS 2019

Saturday, 18 May 2019 by Body Vision Medical
Physicians explore how the cutting-edge technology helps them visualize, access and biopsy small lung lesions in real time with high accuracy, while in the standard bronchoscopy suite.   Body Vision Medical, a medical device company specializing in augmented real-time imaging, artificial intelligence and intra-body navigation, announced today that it has received clearance from the U.S.
Artificial intelligenceaugmented realitycancercomputer visionmachine learningMachine visiononcology
Read more
  • Published in Hardware, Health & life sciences
No Comments

Cantargia: Phase I safety evaluation part of CANFOUR trial of antibody CAN04 completed and phase IIa part being initiated

Sunday, 09 December 2018 by Cantargia
Fri, Dec 07, 2018 15:30 CET Cantargia AB (publ) today announces that all patients in the phase I part of the CANFOUR clinical trial have completed the formal safety evaluation phase of the trial. No dose limiting toxicities (DLTs) were reported at the highest dose level investigated, 10 mg/kg. According to the study protocol, the
antibody CAN04cancerIL1RAPNSCLCpancreatic cáncer
Read more
  • Published in Health & life sciences
No Comments

Roche launches the AVENIO Millisect System for precise and efficient dissection of tissue biopsies

Tuesday, 22 August 2017 by Roche
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced the commercial availability of the AVENIO Millisect System, a tissue dissection instrument that utilizes an automated digitally assisted process to reliably and efficiently isolate clinically relevant cells from formalin-fixed paraffin-embedded (FFPE) tissue slides.   The AVENIO Millisect System addresses challenges inherent in today’s tissue dissection practice in the
cancerdissection systemmolecular pathology
Read more
  • Published in Health & life sciences
No Comments

Merck Develops Alternative CRISPR Genome Editing Method

Friday, 04 August 2017 by Merck
– New technology to improve genome editing, advance new possibilities for research – Creates method to rapidly deploy newly discovered bacterial CRISPR systems in disease-specific applications – Research published in prestigious journal, Nature Communications Merck, a leading science and technology company, has developed a new genome editing tool that makes CRISPR more efficient, flexible and specific,
cancerCRISPRgenome editing
Read more
  • Published in Health & life sciences
No Comments

Mel-Mont Medical, LLC announces the development of Mía by XytoTest®, a self-collected cervical sample that seeks to eradicate cervical cancer

Friday, 28 July 2017 by Mel-Mont Medical
Mía by XytoTest® is a preventive comprehensive diagnostic system developed and patented by the American company, Mel-Mont Medical, LLC founded in 2014 by Frank Meléndez, MSc. and Liliana Montes, MSc. both medical device developers. This innovative system includes a medical device that allows women to self-collect cervical cells in any environment without assistance, to later
cancercervical cancerdiagnostic system
Read more
  • Published in Health & life sciences
No Comments

Varian Launches Game-Changing Treatment Platform to Answer the Global Cancer Challenge.

Monday, 17 July 2017 by varian
Halcyon human-centered design revolutionizes clinical workflow; simplifies and enhances image-guided volumetric IMRT   Varian Medical Systems (NYSE: VAR) today is introducing the Halcyon™ system, an entirely new device for cancer treatment. Engineered to revolutionize clinical workflow, Halcyon simplifies and enhances virtually every aspect of image-guided volumetric intensity modulated radiotherapy (IMRT).  This new treatment system is
cancerIMRT
Read more
  • Published in Hardware, Health & life sciences
No Comments

Tag Cloud

3D 3D camera A-Drop tech aerial robotic manipulation aerial robots Air Conditioning Apple's HomeKit Artificial intelligence augmented reality Autonomous Driving Autonomous vehicles batteries battery biometrics biometrics technologies blockchain cancer connected cars Cryptocurrencies Deep Learning drones electric car external hard drive fast charging flying car intelligent machines IoT Machine vision measuring energy microinstruments microsurgery mobile marketing robot-assisted surgery robotic surgery sample preparation Smart City smart home solar energy Spiral Laminar Flow UAVs vascular graft wireless Wireless charging wireless external hard drive wireless sensor
  • Contacting us
  • Advertise With Us
  • Legal notice and privacy policy
  • Terms of Service
Karma1

© 2017 KARMA1. All Rights Reserved.
Programador Wordpress

TOP